Lethality in mice infected with recombinant vaccinia virus expressing hepatitis C virus core protein

Hepatobiliary and Pancreatic Diseases International

Volumn 2, Issue 3, 2003, Pages 374-382

  Zhang, Hong ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

Animal model; Core protein; Hepatitis C; Vaccinia virus

Indexed keywords

CORE PROTEIN; LUCIFERASE; RECOMBINANT DNA; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VIRUS RNA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CHIMERA; CONTROLLED STUDY; CORRELATION FUNCTION; EXPRESSION VECTOR; GENE DELETION; GENE FUSION; GENE SEQUENCE; GENETIC ENGINEERING; HEPATITIS C; HEPATITIS C VIRUS; IMMUNE RESPONSE; IN VIVO STUDY; INOCULATION; LETHALITY; MORTALITY; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; RNA TRANSLATION; SCID MOUSE; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS RECOMBINANT;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HEPATITIS C; HEPATITIS C ANTIGENS; LUCIFERASES; MICE; MICE, INBRED BALB C; MICE, SCID; RECOMBINANT PROTEINS; VACCINIA; VACCINIA VIRUS; VIRUS REPLICATION;

EID: 0042412234     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Sharara AI, Hunt CM, Hamilton JD. Hepatitis C. Ann Intern Med 1996;125:658-668.
2. Zein NN, Rakela J, Krawitt EL, et al. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Ann Intern Med 1996;125:634-639.
3. Choo QL, Medina-Selby A, Barr P, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991;88:2451-2455.
4. Grakoui A, Wychowski C, Lin C, et al. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 1993;67:1385-1395.
5. Hussp P, Langen H, Mous J, et al. Hepatitis C virus core protein: carboxy-terminal boundaries of two processed species suggest cleavage by a signal peptidase. Virology 1996;224:93-104.
6. Santolini E, Migliaccio G, Monica NL. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol 1994;68:3631-3641.
7. Liu Q, Tackney C, Bhat RA, et al. Regulated processing of hepatitis C virus core protein is linked to subcellular localization. J Virol 1997;71:657-662.
8. Lo SY, Masiarz F, Hwang SB, et al. Differential subcellular localization of hepatitis C virus core gene products. Virology 1995;213:455-461.
9. Lohmann V, Korner F, Kock JO, et al. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999;285:110-113.
10. Ray RB, Meyer K, Steele R, et al. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res 1995;37:209-220.
11. Ray RB, Steele R, Meyer K, et al. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J Bio Chem 1997;272:10983-10986.
12. Srinivas RV, Ray RB, Meyer K, et al. Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication. Virus Res 1996;45:87-92.
13. Shih CM, Lo SJ, Miyamura T, et al. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in Huh-7 cells. J Virol 1993;67:5823-5832.
14. Ray RB, Lagging LM, Meyer K, et al. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 1996;70:4438-4443.
15. Matsumoto M, Hsieh TY, Zhu N, et al. Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol 1997;71:1301-1309.
16. Zhu N, Khoshnan A, Schneider R, et al. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 1998;72:3691-3697.
17. Ruggieri A, Harada T, Matsuura Y, et al. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology 1997;229:68-76.
18. Soguero C, Joo M, Chianese-Bullock KA, et al. Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model. J Virol 2002;76:9345-9354.
19. Chakrabarti S, Brechling K, Moss B. Vaccinia virus expression vector: coexpression of b-galacotosidase provides visual screening of recombinant virus plaques. Mol Cell Biol 1985;5:3403-3409.
20. Zhang H, Hanecak R, Brown-Driver V, et al. Anti-sense oligonucleotide inhibition of hepatitis C virus (HCV) gene expression in livers of mice infected with an HCV-vaccinia virus recombinant. Antimicrob Agents Chemother 1999;43:347-353.
21. Tsukiyama-Kohara K, Iizuka N, Kohara M, et al. Internal ribosome entry site within hepatitis C virus RNA. J Virol 1992;66:1476-1483.
22. Wang C, Le S-Y, Siddiqui A. An RNA pseudoknot is an essential structural element of the internal ribosome entry site located within the hepatitis C virus 5′ non-coding region. RNA 1995;1:526-537.
23. Elroy-Stein O, Moss B. Expression of proteins in mammalian cells using vaccinia viral vectors. In: Ansubel FM, et al (ed). Curr Protocols Mol Biol USA: John Wiley & Sons, Inc. 1998;3:15-16.
24. Hanecak R, Brown-Driver V, Fox MC, et al. Anti-sense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes. J Virol 1996;70:5203-5212.
25. Lo SY, Selby MJ, Ou JH. Interaction between hepatitis C virus core protein and E1 envelop protein. J Virol 1996;70:5177-5182.
26. Large MK, Kittlesen DJ, Hahn YS. Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistance. J Immunol 1999;162:931-938.
27. Barinaga M. Viruses launch their own "star wars". Science 1992;258:1730-1731.
28. Gooding LR. Virus proteins that contact host immune defenses. Cell 1992;71:5-7.
29. Okuda M, Li K, Beard MR, et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002;122:366-375.